Genomic and transcriptomic profiling of inflammatory breast cancer reveals distinct molecular characteristics to non-inflammatory breast cancers Kaiwen ZhouMengmeng ZhangYing Lin Research 19 July 2024
CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer Takumi SatoMasanori OshiKazuaki Takabe Research 17 July 2024
Feasibility and preliminary effects of the Fit2ThriveMB pilot physical activity promotion intervention on physical activity and patient reported outcomes in individuals with metastatic breast cancer Siobhan M. PhillipsJulia StarikovskyWilliam Gradishar Research 16 July 2024
Correction: Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(−) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice Manali A. BhaveJulia C. F. QuintanilhaKevin Kalinsky Correction Open access 13 July 2024
Peripheral blood immune parameters, response, and adverse events after neoadjuvant chemotherapy plus durvalumab in early-stage triple-negative breast cancer Julia FoldiKim R. M. BlenmanLajos Pusztai Research 13 July 2024
Machine learning can reliably predict malignancy of breast lesions based on clinical and ultrasonographic features I. P. C. BuzattoS. A. RecifeD. G. Tiezzi Preclinical study 13 July 2024
The heterogeneity of breast cancer metastasis: a bioinformatics analysis utilizing single-cell RNA sequencing data Ardo SanjayaHana RatnawatiFaiz Rizqy Rahmatilah Research 11 July 2024
Circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers combined with clinicopathological risk has potential to better predict recurrence in stage III breast cancer treated with neoadjuvant chemotherapy: a pilot study Kai-Ye DuShang WuYunjiang Liu Clinical trial 11 July 2024
Three and twelve-month analysis of the PROM-Q study: comparison of patient-reported outcome measures using the BREAST-Q questionnaire in pre- vs. sub-pectoral implant-based immediate breast reconstruction Ritika RampalStacey Jessica JonesBaek Kim Research 10 July 2024
A BRILLIANT-BRCA study: residual breast tissue after mastectomy and reconstruction Orit Kaidar-PersonRenata FaermannDebbie Anaby Research Open access 09 July 2024
Resistance to FOXM1 inhibitors in breast cancer is accompanied by impeding ferroptosis and apoptotic cell death Sandeep KumarYvonne ZieglerBenita S. Katzenellenbogen Research Open access 09 July 2024
A prospective study of vitamin D, proinflammatory cytokines, and risk of fragility fractures in women on aromatase inhibitors for breast cancer Emily LiangMichael BesharaSong Yao Research 08 July 2024
Enhanced cancer cell proliferation and aggressive phenotype counterbalance in breast cancer with high BRCA1 gene expression Kohei ChidaMasanori OshiKazuaki Takabe Research 07 July 2024
Correction to: Ethnic inequities in use of breast conserving surgery and radiation therapy in Aotearoa/New Zealand: which factors contribute? Leah BoyleRoss LawrensonSandar Tin Tin Correction Open access 06 July 2024
The association between infectious agents and breast cancer: a review of the epidemiologic evidence Kristen D. BrantleyRulla M. Tamimi Review 06 July 2024
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105) Jessica Mezzanotte-SharpeAnne ONeillSonya A. Reid Brief Report Open access 05 July 2024
Sustained delivery of celecoxib from nanoparticles embedded in hydrogel injected into the biopsy cavity to prevent biopsy-induced breast cancer metastasis Reese SimmonsHiroyasu KameyamaTakemi Tanaka Research Open access 05 July 2024
Interaction of base excision repair gene polymorphism and estrogen-DNA adducts in breast cancer risk among East Asian women Hsing-Wu ChenWen-Hung KuoChing-Hung Lin Research 05 July 2024
Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective study Francesca MagnoniBeatrice BianchiPaolo Veronesi Research 04 July 2024
Patient-reported observations on medical procedure timeliness (PROMPT) in breast cancer: a qualitative study Marie L. FeffermanTammy K. StumpKatharine Yao Research 04 July 2024
Contrast-enhanced mammography for surveillance in women with a personal history of breast cancer Julia MathesonKenneth ElderAllison Rose Research Open access 04 July 2024
Combination of monensin and erlotinib synergistically inhibited the growth and cancer stem cell properties of triple-negative breast cancer by simultaneously inhibiting EGFR and PI3K signaling pathways Tian FangShiheng HuDawei Guo Research 03 July 2024
The differences between pure and mixed invasive micropapillary breast cancer: the epithelial–mesenchymal transition molecules and prognosis Ozden OzResmiye Irmak YuzugulduDuygu Gurel Research Open access 02 July 2024
Ovarian function recovery in breast cancer patients receiving adjuvant anastrozole treatment: updated results from the phase 3 DATA trial Senna W. M. LammersSandra M. E. Geurtson behalf of the Dutch Breast Cancer Research Group (BOOG) for the DATA investigators Research Open access 28 June 2024
Comparison of proportions and prognostic impact of pathological complete response between evaluations of representative specimen and total specimen in primary breast cancer after neoadjuvant chemoradiotherapy: an ancillary study of JCOG0306 Tadahiko ShienHitoshi TsudaHiroji Iwata Research Open access 27 June 2024
First- vs second-line CDK 4/6 inhibitor use for patients with hormone receptor positive, human epidermal growth-factor receptor-2 negative, metastatic breast cancer in the real world setting Gretchen KimmickAsal PilehvariRoger Anderson Research Open access 26 June 2024
Understanding cardiac events in breast cancer (UCARE): pilot cardio-oncology assessment and surveillance pathway for breast cancer patients Michael CroninAoife LoweryOsama Soliman Methodology Open access 26 June 2024
Prognostic value of the 21-Gene Breast Recurrence Score® assay for hormone receptor-positive/human epidermal growth factor 2-negative advanced breast cancer: subanalysis from Japan Breast Cancer Research Group-M07 (FUTURE trial) Takayuki IwamotoNaoki NiikuraShigehira Saji Research 26 June 2024
Outcomes of older adults with early-stage triple-negative breast cancer (TNBC) receiving chemotherapy: a single-institution experience Akshara Singareeka RaghavendraDiane LiuMeghan Sri Karuturi Research 25 June 2024 Pages: 81 - 90
Feasibility of risk assessment for breast cancer molecular subtypes Anne Marie McCarthySarah EhsanJinbo Chen Research Open access 25 June 2024
The clinical signature of genetic variants and serum levels of macrophage migration inhibitory factor in Egyptian breast cancer patients Mahmoud A. SeliemAhmed M. MohamadinAhmed A. El-Husseiny Research Open access 25 June 2024
SCARB2 associates with tumor-infiltrating neutrophils and predicts poor prognosis in breast cancer Dan ZhangJun FangQingqing Wang Preclinical study 24 June 2024 Pages: 15 - 24
Identifying research priorities for improving information and support for patients undergoing breast cancer surgery: a UK patient-centred priority setting project Emma JohnstonKatherine CowanShelley Potter Research Open access 24 June 2024
Real-world use patterns, effectiveness, and tolerability of sacituzumab govitecan for second-line and later-line treatment of metastatic triple-negative breast cancer in the United States Kevin KalinskyLaura SpringRita Nanda Research Open access 21 June 2024
p53 protein expression patterns associated with TP53 mutations in breast carcinoma Sarah A. AndersonBrooke B. BartowXiao Huang Research Open access 20 June 2024 Pages: 213 - 222
Characteristics of Chinese breast cancer patients with double heterozygosity for BRCA1 and BRCA2 germline pathogenic variants Song WenMeng ZhangYuntao Xie Research 20 June 2024
Reliability of Magseed® marking before neoadjuvant systemic therapy with subsequent contrast-enhanced mammography in patients with non-palpable breast cancer lesions after treatment: the MAGMA study Eva Iglesias BravoAntonio Mariscal MartínezAnabel García Barrado Research Open access 20 June 2024
A novel role of IGFBP5 in the migration, invasion and spheroids formation induced by IGF-I and insulin in MCF-7 breast cancer cells Karem Rodríguez-RojasPedro Cortes-ReynosaEduardo Perez Salazar Research Open access 19 June 2024
Male breast cancer: a multicenter study to provide a guide for proper management Germana LissidiniLuca NicosiaViviana Galimberti Research 19 June 2024
BET-directed PROTACs in triple negative breast cancer cell lines MDA-MB-231 and MDA-MB-436 Maryana TeufelsbauerSandra SticklerGerhard Hamilton Research Open access 19 June 2024
Demographic and clinical characteristics of patients with metastatic breast cancer and leptomeningeal disease: a single center retrospective cohort study Laura A. HuppertSamantha FischMichelle E. Melisko Research Open access 18 June 2024 Pages: 625 - 636
Baseline gut microbiota as a predictive marker for the efficacy of neoadjuvant chemotherapy in patients with early breast cancer: a multicenter prospective cohort study in the Setouchi Breast Project-14 Shogo NakamotoYukiko KajiwaraShinichi Toyooka Research 18 June 2024
Re: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium and the National Cancer Database (NCDB) P. NevenS. HanS. A. Khan Letter to the Editor 16 June 2024 Pages: 233 - 234
Pedigree analysis exploring the inconsistency between diverse phenotypes and testing criteria for germline TP53 mutations in Chinese women with breast cancer Xin HuangChang ChenYidong Zhou Research Open access 15 June 2024 Pages: 653 - 666
Incidence of local breast cancer recurrence with delayed radiation therapy Hayder Hamza AlabediImad Khalid AhmedAhmed Sabah Mohammed Jamil Research 14 June 2024
Adherence to guideline recommendations for follow-up in patients with DCIS at a large teaching hospital in the Netherlands K. K. RajanJ. J. NijveldtA. B. Francken Research 14 June 2024
Patient-reported outcomes and quality of life after breast-conserving surgery, mastectomy, and breast reconstruction assessed using the BREAST-Q questionnaire Shoichi TomitaTakashi YoshitakeYasunobu Terao Research 14 June 2024
Ferroptosis as a promising targeted therapy for triple negative breast cancer Kasra MokhtarpourSepideh RaziNima Rezaei Review 14 June 2024
Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(−) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice Manali A. BhaveJulia C. F. QuintanilhaKevin Kalinsky Research Open access 14 June 2024
Spectrum of germline pathogenic variants in Brazilian hereditary breast/ovarian cancer cases João Paulo FariaJuliana Godoy AssumpçãoLuiz De Marco Research 14 June 2024
